Difference between revisions of "Team:San Andres/Software"
(53 intermediate revisions by the same user not shown) | |||
Line 2: | Line 2: | ||
<head data-gwd-animation-mode="quickMode"> | <head data-gwd-animation-mode="quickMode"> | ||
+ | <title><endnote><head> <title><endnote><head> <meta> <title> | ||
+ | </title> | ||
+ | </head> | ||
+ | |||
+ | <body> | ||
<title>wiki</title> | <title>wiki</title> | ||
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"> | <meta http-equiv="Content-Type" content="text/html; charset=utf-8"> | ||
Line 14: | Line 19: | ||
-webkit-transform: perspective(1400px) matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1); | -webkit-transform: perspective(1400px) matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1); | ||
-webkit-transform-style: preserve-3d; | -webkit-transform-style: preserve-3d; | ||
− | + | background-image: url(https://static.igem.org/mediawiki/2015/8/8a/BBD7.jpg); | |
background-color: rgb(198, 169, 117); | background-color: rgb(198, 169, 117); | ||
} | } | ||
</style> | </style> | ||
− | </ | + | <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1"> |
− | + | <title></title> | |
− | < | + | <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1"> |
+ | <title></title> | ||
+ | <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1"> | ||
+ | <title></title> | ||
+ | <title>wiki</title> | ||
+ | <meta http-equiv="Content-Type" content="text/html; charset=utf-8"> | ||
+ | <meta name="generator" content="Google Web Designer 1.3.2.0521"> | ||
+ | <style type="text/css"> | ||
+ | html, body { | ||
+ | width: 100%; | ||
+ | height: 100%; | ||
+ | margin: 0px; | ||
+ | } | ||
+ | body { | ||
+ | -webkit-transform: perspective(1400px) matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1); | ||
+ | -webkit-transform-style: preserve-3d; | ||
+ | background-color: transparent; | ||
+ | } | ||
+ | </style> | ||
<meta http-equiv="content-type" content="text/html; charset=ISO-8859-1"> | <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1"> | ||
<title></title> | <title></title> | ||
Line 129: | Line 152: | ||
-webkit-transform-style: preserve-3d; | -webkit-transform-style: preserve-3d; | ||
background-color: transparent; | background-color: transparent; | ||
+ | } | ||
+ | .gwd-table-nb4m { | ||
+ | font-size: 24px; | ||
+ | -webkit-transform: translate3d(0px, -2px, 0px); | ||
+ | -webkit-transform-style: preserve-3d; | ||
+ | background-image: none; | ||
+ | background-color: rgb(255, 255, 255); | ||
} | } | ||
.gwd-td-b6db { | .gwd-td-b6db { | ||
Line 509: | Line 539: | ||
-webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0.05, 0, 0, 1); | -webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0.05, 0, 0, 1); | ||
-webkit-transform-style: preserve-3d; | -webkit-transform-style: preserve-3d; | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
} | } | ||
.gwd-img-n53q { | .gwd-img-n53q { | ||
Line 535: | Line 559: | ||
} | } | ||
.gwd-a-36ww { | .gwd-a-36ww { | ||
− | -webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, | + | -webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, -16.1, 0.05, 0, 1); |
-webkit-transform-style: preserve-3d; | -webkit-transform-style: preserve-3d; | ||
} | } | ||
Line 546: | Line 570: | ||
top: 349.384236453212px; | top: 349.384236453212px; | ||
width: 250px; | width: 250px; | ||
+ | } | ||
+ | .gwd-img-zpsn { | ||
+ | position: absolute; | ||
+ | width: 150px; | ||
+ | left: -165.73913043478px; | ||
+ | top: 49.3260869565235px; | ||
+ | } | ||
+ | .gwd-a-d01x { | ||
+ | -webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1); | ||
+ | -webkit-transform-style: preserve-3d; | ||
+ | } | ||
+ | .gwd-table-10nh { | ||
+ | -webkit-transform: translate3d(0px, -2px, 0px); | ||
+ | -webkit-transform-style: preserve-3d; | ||
+ | } | ||
+ | .gwd-table-15ao { | ||
+ | -webkit-transform: translate3d(0px, -2px, 0px); | ||
+ | -webkit-transform-style: preserve-3d; | ||
} | } | ||
</style> | </style> | ||
<!--navigation menu --> | <!--navigation menu --> | ||
<br> | <br> | ||
+ | <table style="width: 968px; height: 34px;" class="gwd-table-nb4m editable gwd-table-15ao"> | ||
+ | <tbody> | ||
+ | <tr heigth="15px"> | ||
+ | </tr> | ||
+ | <tr heigth="75px"> | ||
+ | <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"> | ||
+ | <a href="https://2015.igem.org/Team:San_Andres" style="color: rgb(0, 0, 0);">Home </a> | ||
+ | </td> | ||
+ | <td style="border: 3px solid black;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"> | ||
+ | <a href="https://2015.igem.org/Team:San_Andres/Team" style="color: rgb(0, 0, 0);"> Team</a> | ||
+ | </td> | ||
+ | <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"> | ||
+ | <a href="https://2015.igem.org/Team:San_Andres/Description" style="color: rgb(0, 0, 0);"> Project</a> | ||
+ | </td> | ||
+ | <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"> | ||
+ | <a href="https://2015.igem.org/Team:San_Andres/Parts" style="color: rgb(0, 0, 0);"> Parts</a> | ||
+ | </td> | ||
+ | <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"> | ||
+ | <a href="https://2015.igem.org/Team:San_Andres/Modeling" style="color: rgb(0, 0, 0);"> Modeling</a> | ||
+ | </td> | ||
+ | <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><a href="https://2015.igem.org/Team:San_Andres/Results" style="color: rgb(0, 0, 0);"> Results</a> | ||
+ | </td> | ||
+ | </tr> | ||
+ | </tbody> | ||
+ | </table> | ||
+ | <table style="width: 968px; height: 34px;" class="gwd-table-nb4m editable gwd-table-10nh"> | ||
+ | <tbody> | ||
+ | <tr heigth="15px"> | ||
+ | </tr> | ||
+ | <tr heigth="75px"> | ||
+ | <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"> | ||
+ | <a href="https://2015.igem.org/Team:San_Andres/Notebook" style="color: rgb(0, 0, 0);">Notebook</a> | ||
+ | </td> | ||
+ | <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"> | ||
+ | <a href="https://2015.igem.org/Team:San_Andres/Practices" style="color: rgb(0, 0, 0);"> Human Practices</a> | ||
+ | </td> | ||
+ | <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"> | ||
+ | <a href="https://2015.igem.org/Team:San_Andres/Design" style="color: rgb(0, 0, 0);"> Future Projections</a> | ||
+ | </td> | ||
+ | <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"> | ||
+ | <a href="https://2015.igem.org/Team:San_Andres/Attributions" style="color: rgb(0, 0, 0);"> Attributions</a> | ||
+ | </td> | ||
+ | <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"> | ||
+ | <a href="https://2015.igem.org/Team:San_Andres/Collaborations" style="color: rgb(0, 0, 0);"> Collaborations</a> | ||
+ | </td> | ||
+ | </tr> | ||
+ | </tbody> | ||
+ | </table> | ||
<div class="gwd-div-2ed9"></div> | <div class="gwd-div-2ed9"></div> | ||
<div class="gwd-div-7xzo gwd-a-1thu"> | <div class="gwd-div-7xzo gwd-a-1thu"> | ||
− | <h1> | + | <h1>Abstract</h1> |
− | < | + | <div style="text-align: justify;"><big>The celiac |
− | + | disease affects 1 in 265 people worldwide and 15% | |
− | + | of population in Chile. This in an irreversible autoimmune disease in | |
− | + | which due to the presence of genes HLA DQ2 or HLA DQ8 in those | |
− | + | affected, the consumption of foods containing gluten (all fods derived | |
− | + | from wheat, barley, rye, etc.) cause an inflammation in small intestine | |
− | + | causing multiple effects in the organism (diarrhea, constipation, porr | |
− | + | absorption, among others) significantly affecting their quatily of life.</big> | |
− | + | <br> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | the | + | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | < | + | |
<br> | <br> | ||
− | < | + | <big>Whereas the majority of the world food contains gluten, we |
+ | propose a | ||
+ | treatment for those who can't eat gluten, and can do so without | ||
+ | problems. In detail, our project involves a system able to degrade | ||
+ | gluten via the enzyme KumaMax and report the operation simultaneously | ||
+ | with a red fluorescent protein. The foregoing, works in a genetically | ||
+ | modified E. coli bacteria. With this project, in long run, we hope to | ||
+ | improve the quality of life of all those reported with celiac disease. | ||
+ | People who suffer from gluten intolerance have an adverse reaction to | ||
+ | gluten proteins found in wheat, barley, and rye products.</big> | ||
<br> | <br> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
</div> | </div> | ||
<big><br> | <big><br> | ||
</big> | </big> | ||
+ | <div style="text-align: center;"> | ||
+ | <img style="width: 893px; height: 373px;" alt="File:Ex 2.jpg" src="https://static.igem.org/mediawiki/2015/thumb/9/93/Ex_2.jpg/800px-Ex_2.jpg"> | ||
+ | </div> | ||
+ | <p class="MsoListParagraph" style="text-indent: -18pt;"> | ||
+ | <br> | ||
+ | </p> | ||
+ | <p class="MsoListParagraph" style="text-indent: -18pt;"></p> | ||
</div> | </div> | ||
<br> | <br> | ||
<a href="https://2015.igem.org/Main_Page" class="gwd-a-3xpx gwd-a-36ww"> | <a href="https://2015.igem.org/Main_Page" class="gwd-a-3xpx gwd-a-36ww"> | ||
− | <img style="border: 0px solid ; width: 150px; height: 150px | + | <img style="border: 0px solid ; width: 150px; height: 150px; left: 989px; top: 49px;" alt="" src="https://static.igem.org/mediawiki/igem.org/6/60/Igemlogo_300px.png" class="gwd-img-kwqf"> |
</a> | </a> | ||
− | <a href="https://igem.org/Team_List?year=2015" class="gwd-a-3xpx"> | + | <a href="https://igem.org/Team_List?year=2015" class="gwd-a-3xpx gwd-a-d01x"> |
− | <img src="https://static.igem.org/mediawiki/2015/thumb/ | + | <img src="https://static.igem.org/mediawiki/2015/thumb/8/85/Logo_Definitvo.png/654px-Logo_Definitvo.png" class="gwd-img-zpsn"> |
</a> | </a> | ||
<br> | <br> | ||
<br> | <br> | ||
− | < | + | <br> |
− | + | <br> | |
− | + | <br> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | < | + | |
</body> | </body> | ||
</html> | </html> |
Latest revision as of 01:22, 15 September 2015
Home | Team | Project | Parts | Modeling | Results |
Notebook | Human Practices | Future Projections | Attributions | Collaborations |
Abstract
The celiac
disease affects 1 in 265 people worldwide and 15%
of population in Chile. This in an irreversible autoimmune disease in
which due to the presence of genes HLA DQ2 or HLA DQ8 in those
affected, the consumption of foods containing gluten (all fods derived
from wheat, barley, rye, etc.) cause an inflammation in small intestine
causing multiple effects in the organism (diarrhea, constipation, porr
absorption, among others) significantly affecting their quatily of life.
Whereas the majority of the world food contains gluten, we propose a treatment for those who can't eat gluten, and can do so without problems. In detail, our project involves a system able to degrade gluten via the enzyme KumaMax and report the operation simultaneously with a red fluorescent protein. The foregoing, works in a genetically modified E. coli bacteria. With this project, in long run, we hope to improve the quality of life of all those reported with celiac disease. People who suffer from gluten intolerance have an adverse reaction to gluten proteins found in wheat, barley, and rye products.
Whereas the majority of the world food contains gluten, we propose a treatment for those who can't eat gluten, and can do so without problems. In detail, our project involves a system able to degrade gluten via the enzyme KumaMax and report the operation simultaneously with a red fluorescent protein. The foregoing, works in a genetically modified E. coli bacteria. With this project, in long run, we hope to improve the quality of life of all those reported with celiac disease. People who suffer from gluten intolerance have an adverse reaction to gluten proteins found in wheat, barley, and rye products.